Stephenson Cancer Center at OU Medicine in Oklahoma City recently announced it will begin using CAR T therapy to treat advanced lymphoma in adults.
CAR T utilizes the patients' own T cells, which are collected, then sent to a company and injected with a gene that fights cancer. The specially engineered cells are then transfused back to the patient to attack the cancer in a revolutionary way -- and patients should require only one treatment.
Oklahoma Blood Institute is helping with this breakthrough treatment by collecting CAR T patients' blood at its facility in Oklahoma City, so that the T cells can be separated from the blood and then programmed to fight cancer.
Stephenson Cancer Center is designated by the National Cancer Institute.
Oklahoma Blood Institute is the sixth largest non-profit blood collector in the U.S.